The Pharmacological Mechanisms of Xiaochaihutang in Treating Breast Cancer Based on Network Pharmacology

被引:6
|
作者
Zheng, Lin [1 ]
Jiang, Hongnan [2 ]
Li, Ruoqi [3 ]
Song, Liying [4 ]
Chen, Ruihan [5 ]
Dong, Honglin [1 ]
机构
[1] Second Hosp Shanxi Med Univ, Dept Vasc Surg, Taiyuan 030000, Peoples R China
[2] Second Hosp Shanxi Med Univ, Dept Breast Surg, Taiyuan 030000, Peoples R China
[3] Third Hosp Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Gen Surg Dept, Taiyuan 030032, Peoples R China
[4] Shanxi Med Univ, Taiyuan 030607, Shanxi, Peoples R China
[5] Shanxi Med Univ, Clin Med Coll 1, Taiyuan 030001, Peoples R China
关键词
ARREST; CELLS;
D O I
10.1155/2022/3900636
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background. As a classic prescription in Chinese medicine treatment, Xiaochaihutang (XCHT) can improve the clinical effect and reduce serum tumor markers in patients with breast cancer (BC). However, there has not been any study to confirm the mechanism. We used bioinformatics analysis and network pharmacology to find the potential targets. Methods. The differentially expressed genes (DEGs) of BC were identified from the Cancer Genome Atlas (TCGA) dataset. Then, we utilized weighted coexpression network analysis (WGCNA) with the same dataset. The target genes of BC were obtained by comparing genes of DEGs and in significant modules of WGCNA. Drug targets of XCHT from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) database were intersected with the targets of BC. The protein-protein interaction (PPI) of the drug targets was analysed by using the STRING database. We utilized the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes analysis (KEGG) enrichment analysis to identify the specific pathways and key target proteins. Receiver operator characteristic (ROC) curve was used as the verification of drug targets. Molecular docking was performed to visualize the patterns of interactions between the effective molecule and targeted protein. Results. We obtained a set of 21 target genes, which mainly encode neurotransmitter receptors or related transporters, such as OPRD1, 5-HT2A, and so on. In addition, enrichment analyses of 21 target genes showed that they were mainly concentrated in pathways related to the nervous system. Molecular docking was performed on the target gene of BC. Six active compounds can enter the active pocket of target gene, namely, naringenin, beta-sitosterol, coumestrol, nuciferine, beta-sitosterol, and protopine, thereby exerting potential therapeutic effects in BC. Conclusions. Our analysis shows that the mechanism of XCHT in the treatment of BC is mainly acting on the neurogenesis in the microenvironment of breast tumor tissue.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Network pharmacology: curing causal mechanisms instead of treating symptoms
    Nogales, Cristian
    Mamdouh, Zeinab M.
    List, Markus
    Kiel, Christina
    Casas, Ana I.
    Schmidt, Harald H. H. W.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (02) : 136 - 150
  • [42] Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer
    Gao, Jia
    Yang, Sifu
    Xie, Guanqun
    Pan, Jieli
    Zhu, Feiye
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 1947 - 1961
  • [43] Role and molecular mechanisms of HuangQiSiJunZi decoction for treating triple-negative breast cancer as explored via network pharmacology and bioinformatics analyses
    Wang, Decai
    Xie, Dongqing
    Meng, Shuai
    Mi, Jiwei
    Wang, Haiming
    Li, Lingsheng
    Zhang, Yin
    Cui, Yixin
    BMC CANCER, 2024, 24 (01)
  • [44] Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer
    Wang, Zefeng
    Cui, Qianfei
    Shi, Ling
    Zhang, Meiling
    Song, Peng
    Duan, Dongzhu
    Guo, Wenjing
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2022, 17 (03) : 297 - 311
  • [45] Exploring the Mechanism of Curcumae Rhizoma in Treating Prostate Cancer Based on Network Pharmacology
    Zhu, Wenhui
    Mao, Lili
    Yang, Ruijie
    Tong, Shijun
    Zhai, Jing
    Ding, Guanxiong
    LATIN AMERICAN JOURNAL OF PHARMACY, 2024, 43 (01): : 25 - 34
  • [46] Network Pharmacology-Based Study on the Mechanism of Aloe Vera for Treating Cancer
    Xie, Jing
    Wu, Jun
    Yang, Sihui
    Zhou, Huaijun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [47] Pharmacological targets and therapeutic mechanisms of Arabic gum in treating diabetic wounds: insights from network pharmacology and experimental validation
    Chai, Langjie
    Chen, Danyang
    Ye, Lili
    Peng, Pan
    Wang, Haijie
    Al Saleh, Nouf
    Al-Kenani, Nader S.
    Guo, Jia
    Li, Qianqian
    Guo, Liang
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [48] Artificial intelligence and network pharmacology based investigation of pharmacological mechanism and substance basis of Xiaokewan in treating diabetes
    Zhu, Chunyan
    Cai, Tingting
    Jin, Ying
    Chen, Jiayun
    Liu, Guoqiang
    Xu, Niusheng
    Shen, Rong
    Chen, Yuhong
    Han, Luying
    Wang, Suping
    Wu, Caisheng
    Zhu, Mingshe
    PHARMACOLOGICAL RESEARCH, 2020, 159
  • [49] Exploring the pharmacological mechanism of Duhuo Jisheng Decoction in treating intervertebral disc degeneration based on network pharmacology
    Song, Chao
    Chen, Rui
    Cheng, Kang
    Zhou, Daqian
    Mei, Yongliang
    Yan, Jiafu
    Liu, Zongchao
    MEDICINE, 2023, 102 (22) : E33917
  • [50] Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology
    Wu, Tianhui
    Xiang, Min
    Li, Yujiao
    Gao, Yahan
    Teng, Da
    Sun, Minxuan
    Guo, Weiqiang
    Zhou, Yuanshuai
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (12): : 341